fda shortage semaglutide injection products resolved feb 21 2025 declares over Wegovy Shortage Resolved: 2026 Availability

It remains clear and colorless, just like regular sterile water, with comparable osmolality and pH

As we look to 2026, the story becomes one of defining firsts: the debut of oral GLP-1s, the first loss of exclusivity for a GLP-1 receptor antagonist, and landmark coverage decisions such as obesity medications entering Medicare formularies for obesity as a standalone indication

In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by licensed pharmacies due to insufficient human safety data

Dont use GLP-1 agonists while pregnant, breastfeeding, or trying to conceive While GLP-1 drugs may improve fertility, its unknown how they affect fetal development

DSIP doesn't knock you out instantlyit works with your body's natural sleep systems, so give it time to take effect